VTYX FY 2024 Earnings — Ventyx Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

VTYXVentyx Biosciences, Inc.

$1B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$148M

Net Income

-$135M

EPS (Diluted)

$-1.97

Cash Flow

Operating Cash Flow

-$131M

Free Cash Flow

-$131M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$277M

Total Liabilities

$23M

Stockholders' Equity

$254M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$148M	-$208M	+28.6%
Net Income	-$135M	-$193M	+30.0%